Polyamidoamine Dendrimers Functionalized with ZnO-Chitosan Nanoparticles as an Efficient Surface for L-asparaginase Immobilization

被引:0
作者
Sudabeh Iraninasab
Ahmad Homaei
Elaheh Mosaddegh
Masoud Torkzadeh-Mahani
机构
[1] University of Hormozgan,Department of Marine Biology, Faculty of Marine Science and Technology
[2] Graduate University of Advanced Technology,Department of New Materials, Institute of Science and High Technology and Environmental Sciences
[3] Graduate University of Advanced Technology,Department of Biotechnology, Institute of Science and High Technology and Environmental Sciences
来源
Applied Biochemistry and Biotechnology | 2024年 / 196卷
关键词
Dendrimer; L-asparaginase; Lymphoblastic Leukemia; Nanocarrier;
D O I
暂无
中图分类号
学科分类号
摘要
In this study, the third-generation polyamidoamine dendrimer was functionalized with a 5-amino-1H-tetrazole heterocycle to load the synthesis enzyme and its surface groups. Then, chitosan was attached to the dendrimer by a suitable linker, and finally, zinc oxide nanoparticles were inserted into dendrimer cavities to increase loading. FTIR, FESEM, TEM, and DLS analysis showed that this new dendrimer has specific branches, and ZnO nanoparticles were spread between the branches and connected with the branches and chitosan biopolymer. Also proved the presence of stabilized L-asparaginase enzyme and ZnO nanoparticles in the designed system. Furthermore, the extent of L-asparaginase enzyme loading and release was investigated in the laboratory with a dialysis bag. Examining the toxicity of the new third-generation polyamidoamine (PAMAM) dendrimeric nanocarrier based on chitosan-zinc oxide biopolymer (PAMAM-G3@ZnO-Cs nanocarrier) on the Jurkat cell line (human acute lymphoblastic leukemia) at pH 7.4 showed that this nanocarrier effectively encapsulates the drug L-asparaginase and slowly releases it and also preventing the growth of cancer cells. The activity of the loaded enzyme in the nanocarrier and the free enzyme was calculated. During the investigations, it was found that the enzyme attached to the nanocarrier is more stable than the free enzyme at optimal pH and temperature and at high temperatures, acidic and basic pHs. Vmax and Km values were lower for loaded enzymes. The synthesized PAMAM-G3@ZnO-Cs nanocarrier can be a promising candidate in the pharmaceutical industry and medical science for cancer treatment due to its biocompatibility, non-toxicity, stability, and slow release of L-asparaginase.
引用
收藏
页码:971 / 991
页数:20
相关论文
共 345 条
[1]  
Cantor JR(2012)Engineering reduced-immunogenicity enzymes for amino acid depletion therapy in cancer Methods in Enzymology 502 291-319
[2]  
Panayiotou V(2013)Middleware for pervasive computing: A survey Pervasive and Mobile Computing 9 177-200
[3]  
Agnello G(2007)L-asparaginase: A promising chemotherapeutic agent Critical Reviews in Biotechnology 27 45-62
[4]  
Georgiou G(2014)Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology Advanced Drug Delivery Reviews 66 2-25
[5]  
Stone EM(2010)Synthesis and characterization of PVP-functionalized superparamagnetic Fe3O4 nanoparticles as an MRI contrast agent Express Polymer Letters 4 329-338
[6]  
Raychoudhury V(2009)Hydrogel-magnetic nanoparticles with immobilized L-asparaginase for biomedical applications Journal of Materials Science: Materials in Medicine 20 1307-1314
[7]  
Cao J(2010)Multifunctional magnetoplasmonic nanoparticle assemblies for cancer therapy and diagnostics (theranostics) Macromolecular rapid Communications 31 228-236
[8]  
Kumar M(2005)Birth of a new macromolecular architecture: Dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry Progress in Polymer Science 30 294-324
[9]  
Zhang D(2010)Production, purification and characterization of L-asparaginase from Streptomyces gulbargensis Brazilian Journal of Microbiology 41 173-178
[10]  
Verma N(1993)A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates Clinical Science (London, England: 1979) 84 407-412